FDA Inspection 1283224 — Azenta US Inc
The FDA completed an inspection of Azenta US Inc on Sep 16, 2025 in Plainfield, IN. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Sep 16, 2025
- Fiscal Year
- 2025
- Product Type
- Biologics
- Project Area
- Human Cellular, Tissue, and Gene Therapies
- Location
- Plainfield, IN (United States)